Skip to content

Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution

Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution (MPDS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01341977
Enrollment
573
Registered
2011-04-26
Start date
2009-11-30
Completion date
2010-05-31
Last updated
2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Contact Lens Wearers

Keywords

Contact Lenses, Contact Lens Care, Multi-Purpose Solution

Brief summary

The purpose of this study is to determine if Alcon MPDS is safe and effective for silicone hydrogel and soft hydrogel contact lens wearers.

Detailed description

The purpose of this study is to determine if Alcon Multi-Purpose Disinfecting Solution (MPDS) is safe and effective for silicone hydrogel and soft hydrogel contact lens wearers.

Interventions

DEVICEReNu Fresh MPS

ReNu Fresh MPS is a marketed product indicated for cleaning, removing protein deposits, rinsing, disinfecting and storage of soft contact lenses.

DEVICEAlcon MPDS

Multi-Purpose Solution intended for use with silicone hydrogel and soft contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Silicone hydrogel or soft contact lens wearers who wear their lenses daily wear (i.e. disinfect lenses every night). * Patient must be able to read. * Vision correctable to 20/30 or better with contact lenses.

Exclusion criteria

* Sensitivity to multi-purpose solutions. * Using any topical ocular OTC or prescribed topical ocular medications. * History or current ocular infections or ocular inflammatory events. * Ocular surgery within the past year. * With a medical condition or using medications that cause ocular side effects. * Participation in any investigational study within the past 30 days.

Design outcomes

Primary

MeasureTime frameDescription
Subjective AcceptanceDay 90Lens Moisture Subject Rated Likert Item (1-Strongly Agree to 5-Strongly Disagree)

Countries

United States

Participant flow

Participants by arm

ArmCount
Alcon MPDS
Alcon Multi-Purpose Disinfecting Solution (MPDS)
288
ReNu Fresh Multi-Purpose Solution
ReNu Fresh Multi-Purpose Solution (MPS)
285
Total573

Baseline characteristics

CharacteristicTotalAlcon MPDSReNu Fresh Multi-Purpose Solution
Age, Categorical
<=18 years
31 Participants8 Participants23 Participants
Age, Categorical
>=65 years
6 Participants1 Participants5 Participants
Age, Categorical
Between 18 and 65 years
536 Participants279 Participants257 Participants
Age, Continuous33.9 years
STANDARD_DEVIATION 11
34 years
STANDARD_DEVIATION 10.7
33.9 years
STANDARD_DEVIATION 11.4
Region of Enrollment
United States
573 participants288 participants285 participants
Sex: Female, Male
Female
411 Participants214 Participants197 Participants
Sex: Female, Male
Male
162 Participants74 Participants88 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2880 / 285
serious
Total, serious adverse events
0 / 2881 / 285

Outcome results

Primary

Subjective Acceptance

Lens Moisture Subject Rated Likert Item (1-Strongly Agree to 5-Strongly Disagree)

Time frame: Day 90

ArmMeasureValue (MEAN)Dispersion
Alcon MPDSSubjective Acceptance1.9 units on a scaleStandard Deviation 0.8
ReNu Fresh Multi-Purpose SolutionSubjective Acceptance2.1 units on a scaleStandard Deviation 1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026